"L.R.S. News Article Index"
The MISS Foundation's Homepage    |    L.R.S. Homepage    |    L.R.S. News Article Index


Should older women have antepartum testing to prevent unexplained stillbirth?



Obstet Gynecol. 2004 Jul;104(1):56-64.
  
Should older women have antepartum testing to prevent unexplained stillbirth?

Fretts RC, Elkin EB, Myers ER, Heffner LJ.

Harvard Medical Associates, Brigham and Women's Hospital and Harvard Medical 
School, Boston, Massachusetts, USA. ruth_fretts@vmed.org

OBJECTIVE: Older women are at an increased risk for unexplained stillbirth late 
in pregnancy. The purpose of this study was to compare 3 strategies for the 
prevention of unexplained fetal death in women aged 35 years and older. We 
compared usual care (no antepartum testing or induction before 41 weeks), weekly 
testing at 37 weeks with induction after a positive test, and no testing with 
induction at 41 weeks. 

METHOD: We used a Markov model to quantify the risks and benefits of each 
strategy in terms of the number of antepartum tests, inductions, and additional 
cesarean deliveries per fetal death averted. Probability data used in the model 
were derived from obstetrical databases and the literature. 

RESULTS: Without a strategy of antepartum surveillance between 37 and 41 weeks, 
women aged 35 years and older would experience 5.2 unexplained fetal deaths per 
1,000 pregnancies. For nulliparous women 35 and older, weekly antepartum testing 
initiated at 37 weeks would avert 3.9 fetal deaths per 1,000 pregnancies but 
would require 863 antepartum tests, 71 inductions, and 14 additional cesarean 
deliveries per fetal death averted. A strategy of no testing but induction at 
41 weeks would avert 0.9 fetal deaths per 1,000 pregnancies and require 469 
inductions and 219 additional cesareans per fetal death averted. 

CONCLUSION: A strategy of antepartum testing in older women would reduce the 
number of unexplained stillbirths at term and would result in fewer inductions 
and cesareans per fetal death averted than a strategy of no antepartum testing 
but induction at 41 weeks.

PMID: 15229001 [PubMed - indexed for MEDLINE]


Link to Source
 

The M.I.S.S. Foundation is a nonprofit, 501(c)3, international organization which provides immediate and ongoing support to grieving families, empowerment through community volunteerism opportunities, public policy and legislative education, and programs to reduce infant and toddler death through research and education.